Related Experiment Videos
[Primary and secondary prevention for erysipelas]
1Service de Médecine Interne, Maladies Infectieuses et Tropicales, CHU de Poitiers, France.
Annales De Dermatologie Et De Venereologie
|April 25, 2001
Summary
Erysipelas, a bacterial skin infection, often recurs due to underlying health issues and local factors. Preventing recurrence involves treating the infection, stasis, and wounds, with antibiotics for high-risk patients.
Area of Science:
- Dermatology
- Infectious Diseases
- Microbiology
Background:
- Erysipelas is a bacterial infection affecting the deep skin layers, with recurrence being a significant clinical challenge.
- Predisposing factors include systemic conditions like alcoholism, diabetes, and immunodeficiency, alongside local issues such as athlete's foot and venous stasis.
Framework:
- Understanding predisposing factors is crucial for explaining the prevalence of erysipelas in lower limbs and its recurrent nature.
- The study highlights the importance of addressing underlying causes to manage and prevent erysipelas.
Implementation:
- Effective management emphasizes correct disease treatment, alongside addressing venous/lymphatic stasis and wounds.
- Preventive antibiotic therapy, particularly prolonged Macrolide or Penicillin use, is recommended for patients with multiple risk factors and frequent recurrences.
Implications:
- While primary prevention strategies targeting predisposing factors are proposed, their efficacy requires further demonstration.
- The roles of eradicating nasopharyngeal streptococcal carriage and vaccination in erysipelas prevention remain unproven.